XML 61 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity And Stock-Based Compensation (Stock Option Activity) (Details)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Stockholders’ Equity And Stock-Based Compensation [Abstract]  
Outstanding as of, Beginning | shares 2,663,727
Options granted | shares 104,000
Options exercised | shares (203,640)
Options forfeited/canceled | shares (34,639)
Outstanding as of, Ending | shares 2,529,448
Vested and expected to vest at December 31, 2022 | shares 2,529,448
Exercisable at December 31, 2022 | shares 2,270,464
Weighted Average Exercise Price, Outstanding as of, Beginning | $ / shares $ 11.56
Weighted Average Exercise Price, Options granted | $ / shares 36.50
Weighted Average Exercise Price, Options exercised | $ / shares 15.56
Weighted Average Exercise Price, Options forfeited/cancelled | $ / shares 20.59
Weighted Average Exercise Price, Outstanding as of, Ending | $ / shares 12.13
Weighted Average Exercise Price, Vested and expected to vest at December 31, 2022 | $ / shares 12.13
Weighted Average Exercise Price, Exercisable at December 31, 2022 | $ / shares $ 10.02
Weighted Average Remaining Contractual Term 3 years 11 months 8 days
Weighted Average Remaining Contractual Term, Vested and expected to vest at December 31, 2022 3 years 11 months 8 days
Weighted Average Remaining Contractual Term, Exercisable at December 31, 2022 3 years 5 months 4 days
Outstanding, Aggregate Intrinsic Value | $ $ 49.6
Aggregate Intrinsic Value, Vested and expected to vest at December 31, 2022 | $ 49.6
Aggregate Intrinsic Value, Exercisable at December 31, 2022 | $ $ 46.9